Kunlun Capital logo

Kunlun Capital

Asia, Beijing, China, Beijing

Description

Kunlun Capital seeks to invest in technologically innovative companies.

Investor Profile

Kunlun Capital has made 4 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Angel (25%)
  • Series E (25%)
  • Series C (25%)
  • Series A (25%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Construction
  • Product Design
  • Cloud Computing
  • Information Technology
  • Software
  • Biotechnology
  • Health Care
  • Aerospace
  • Satellite Communication
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kunlun Capital frequently co-invest with?

UnityVC
Asia, Beijing, China, Beijing
Co-Investments: 1
K2VC
Asia, Beijing, China, Beijing
Co-Investments: 1
Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Vision Plus Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
IV
Europe, Lazio, Italy, Rome
Co-Investments: 1
Co-Investments: 1
Sequoia Capital (SSF)
North America, California, United States, Menlo Park
Co-Investments: 1
HC
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
CAS Star
Asia, Hunan, China, Xian
Co-Investments: 1
Boyu Capital
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Kunlun Capital?

HongQing Technology

Daxing, Beijing, China

HongQing Technology is a satellite networking solution provider.

AerospaceManufacturingSatellite Communication
Series AJan 23, 2025
Amount Raised: $41,167,511
Startous fusion

Xian Shi, Shaanxi, China

Startous fusion focuses on commercializing fusion energy aiming to build commercial controllable fusion reactor.

ConstructionManufacturingProduct Design
AngelJun 16, 2022
XSKY Data Technology

Haidian, Beijing, China

China-based technical company focusing on software-defined-infrastructure products and services.

Cloud ComputingInformation TechnologySoftware
Series ESep 3, 2021
Amount Raised: $110,017,820
Heyuan Biotechnology

Shanghai, Shanghai, China

Heyuan Biotechnology is a biotechnology company focusing on the field of gene therapy services.

BiotechnologyHealth Care
Series CJun 1, 2020
Amount Raised: $300,000,000